Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
The robust glycolytic metabolism of glioblastoma multiforme (GBM) has proven them susceptible to increases in oxidative metabolism induced by the pyruvate mimetic dichloroacetate (DCA). Recent reports demonstrate that the anti-diabetic drug metformin enhances the damaging oxidative stress associated...
Main Authors: | Nathan P Ward, Angela M Poff, Andrew P Koutnik, Dominic P D'Agostino |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5482478?pdf=render |
Similar Items
-
Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.
by: A M Poff, et al.
Published: (2015-01-01) -
Commentary: Ketone Diester Ingestion Impairs Time-Trial Performance in Professional Cyclists
by: Brianna J. Stubbs, et al.
Published: (2018-03-01) -
Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma
by: Zachary M. Augur, et al.
Published: (2018-10-01) -
ACADEMICIAN V.M. POSTOLATY - 75 years
by: Berzan V.P.
Published: (2012-08-01) -
Genetic variants for personalised management of very low carbohydrate ketogenic diets
by: Lucia Aronica, et al.